CEFIXIME
| Brand name | SUPRAX |
|---|---|
| Active ingredient | CEFIXIME |
| Strength | 500MG/5ML |
| Dosage form | FOR SUSPENSION |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | February 2013 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 9233112 | December 2028 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.